| Multiple Myeloma |
1 |
1 |
| Europe |
0 |
0.74 |
| Autologous stem cell transplant |
0 |
0.61 |
| Transplantation |
0 |
0.6 |
| Stem Cell Research and Therapy |
0 |
0.54 |
| Bone Marrow Transplant |
0 |
0.52 |
| Biologic Therapy |
0 |
0.44 |
| Adverse Effects |
0 |
0.3 |
| Clinical Research |
0 |
0.3 |
| Geriatrics |
0 |
0.3 |
| Bone Marrow |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.2 |
| Patient Safety |
0 |
0.2 |
| Bone |
0 |
0.15 |
| Cancer |
0 |
0.15 |
| Concerns of Elderly |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Immunomodulator |
0 |
0.15 |
| Refractory |
0 |
0.15 |
| Toxicology |
0 |
0.15 |
| UK Site Content |
0 |
0.15 |